We have published a review article on pluripotent Muse cell for cell therapy against ischemic stroke just now.
Kuroda S, Koh M, Hori E, Hayakawa Y, Akai T.
Adv Exp Med Biol. 2018;1103:187-198. doi: 10.1007/978-4-431-56847-6_10.
Muse Cell: A New Paradigm for Cell Therapy and Regenerative Homeostasis in Ischemic Stroke.
Abstract
Multilineage-differentiating stress enduring (Muse) cells are one of the most promising donor cells for cell therapy against ischemic stroke, because they can differentiate into any type of cells constructing the central nervous system (CNS), including the neurons. They can easily be isolated from the bone marrow stromal cells (BMSCs), which may also contribute to functional recovery after ischemic stroke as donor cells. In this chapter, we concisely review their biological features and then future perspective of Muse cell transplantation for ischemic stroke. In addition, we briefly refer to the surprising role of Muse cells to maintain the homeostasis in the living body under both physiological and pathological conditions.